Market Overview

UPDATE: Oppenheimer Initiates Quest Diagnostics at Underperform on Restructuring, Industry Risks

Share:
Related DGX
10 Biggest Price Target Changes For Friday
Benzinga's Top Upgrades, Downgrades For November 30, 2018

Oppenheimer initiated coverage on Quest Diagnostics (NYSE: DGX) with an Underperform rating and a $53.00 price target.

Oppenheimer noted, "While management is taking steps to streamline the company's operations, we believe the industry's headwinds will overshadow progress in the near term. Although a 4.95% reimbursement cut is on the table, if sequestration is averted, we think the industry may have to absorb an even greater pricing decline in a grand bargain scenario. We estimate that, even with the company's proposed cost reductions, reimbursement headwinds will still dominate. With volume growth trailing the industry and cost cutting a multi-year process, we believe the shares of DGX will trail its primary competitor."

Quest Diagnostics closed at $57.94 on Monday.

Latest Ratings for DGX

DateFirmActionFromTo
Nov 2018BarclaysMaintainsOverweightOverweight
Nov 2018Credit SuisseMaintainsOutperformOutperform
Nov 2018Morgan StanleyMaintainsOverweightOverweight

View More Analyst Ratings for DGX
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Initiation Analyst Ratings

 

Related Articles (DGX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
DESPKeyBancInitiates Coverage On0.0
MELIKeyBancInitiates Coverage On0.0
ALBKeyBancMaintains120.0
AVNSKeyBancMaintains67.0
ABTCredit SuisseInitiates Coverage On82.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Oppenheimer Initiates Laboratory Corporation of America Holdings at Perform on Industry Headwinds

UPDATE: Bank of America Upgrades Tyson Foods to Buy on Chicken and Beef Fundamentals